Auto - Parts
Compare Stocks
2 / 10Stock Comparison
THRM vs DORM
Revenue, margins, valuation, and 5-year total return — side by side.
Auto - Parts
THRM vs DORM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Auto - Parts | Auto - Parts |
| Market Cap | $944M | $3.72B |
| Revenue (TTM) | $1.53B | $2.15B |
| Net Income (TTM) | $23M | $190M |
| Gross Margin | 23.6% | 40.7% |
| Operating Margin | 4.7% | 15.6% |
| Forward P/E | 11.6x | 15.0x |
| Total Debt | $295M | $633M |
| Cash & Equiv. | $161M | $49M |
THRM vs DORM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Gentherm Incorporat… (THRM) | 100 | 75.7 | -24.3% |
| Dorman Products, In… (DORM) | 100 | 178.1 | +78.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: THRM vs DORM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
THRM is the clearest fit if your priority is value and momentum.
- Lower P/E (11.6x vs 15.0x)
- +19.1% vs DORM's +0.5%
DORM carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.85
- Rev growth 6.0%, EPS growth 8.1%, 3Y rev CAGR 7.1%
- 129.7% 10Y total return vs THRM's -14.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.0% revenue growth vs THRM's 2.6% | |
| Value | Lower P/E (11.6x vs 15.0x) | |
| Quality / Margins | 8.8% margin vs THRM's 1.5% | |
| Stability / Safety | Beta 0.85 vs THRM's 1.43 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +19.1% vs DORM's +0.5% | |
| Efficiency (ROA) | 7.6% ROA vs THRM's 1.6%, ROIC 13.9% vs 7.3% |
THRM vs DORM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
THRM vs DORM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DORM leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
DORM and THRM operate at a comparable scale, with $2.2B and $1.5B in trailing revenue. DORM is the more profitable business, keeping 8.8% of every revenue dollar as net income compared to THRM's 1.5%. On growth, THRM holds the edge at +11.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.5B | $2.2B |
| EBITDAEarnings before interest/tax | $127M | $377M |
| Net IncomeAfter-tax profit | $23M | $190M |
| Free Cash FlowCash after capex | $79M | $71M |
| Gross MarginGross profit ÷ Revenue | +23.6% | +40.7% |
| Operating MarginEBIT ÷ Revenue | +4.7% | +15.6% |
| Net MarginNet income ÷ Revenue | +1.5% | +8.8% |
| FCF MarginFCF ÷ Revenue | +5.1% | +3.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.3% | +4.2% |
| EPS Growth (YoY)Latest quarter vs prior year | — | -23.5% |
Valuation Metrics
THRM leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 18.8x trailing earnings, DORM trades at a 63% valuation discount to THRM's 51.4x P/E. On an enterprise value basis, THRM's 8.2x EV/EBITDA is more attractive than DORM's 10.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $944M | $3.7B |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $4.3B |
| Trailing P/EPrice ÷ TTM EPS | 51.35x | 18.75x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.57x | 15.05x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.25x |
| EV / EBITDAEnterprise value multiple | 8.21x | 10.41x |
| Price / SalesMarket cap ÷ Revenue | 0.63x | 1.75x |
| Price / BookPrice ÷ Book value/share | 1.32x | 2.59x |
| Price / FCFMarket cap ÷ FCF | 15.45x | 49.18x |
Profitability & Efficiency
DORM leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
DORM delivers a 13.1% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $3 for THRM. THRM carries lower financial leverage with a 0.41x debt-to-equity ratio, signaling a more conservative balance sheet compared to DORM's 0.43x. On the Piotroski fundamental quality scale (0–9), DORM scores 7/9 vs THRM's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +3.2% | +13.1% |
| ROA (TTM)Return on assets | +1.6% | +7.6% |
| ROICReturn on invested capital | +7.3% | +13.9% |
| ROCEReturn on capital employed | +8.2% | +18.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.41x | 0.43x |
| Net DebtTotal debt minus cash | $134M | $584M |
| Cash & Equiv.Liquid assets | $161M | $49M |
| Total DebtShort + long-term debt | $295M | $633M |
| Interest CoverageEBIT ÷ Interest expense | 5.83x | 8.24x |
Total Returns (Dividends Reinvested)
DORM leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DORM five years ago would be worth $11,922 today (with dividends reinvested), compared to $4,200 for THRM. Over the past 12 months, THRM leads with a +19.1% total return vs DORM's +0.5%. The 3-year compound annual growth rate (CAGR) favors DORM at 12.3% vs THRM's -19.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -16.3% | +0.3% |
| 1-Year ReturnPast 12 months | +19.1% | +0.5% |
| 3-Year ReturnCumulative with dividends | -48.0% | +41.6% |
| 5-Year ReturnCumulative with dividends | -58.0% | +19.2% |
| 10-Year ReturnCumulative with dividends | -14.9% | +129.7% |
| CAGR (3Y)Annualised 3-year return | -19.6% | +12.3% |
Risk & Volatility
Evenly matched — THRM and DORM each lead in 1 of 2 comparable metrics.
Risk & Volatility
DORM is the less volatile stock with a 0.85 beta — it tends to amplify market swings less than THRM's 1.43 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. THRM currently trades 78.0% from its 52-week high vs DORM's 74.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.43x | 0.85x |
| 52-Week HighHighest price in past year | $39.48 | $166.89 |
| 52-Week LowLowest price in past year | $25.47 | $98.44 |
| % of 52W HighCurrent price vs 52-week peak | +78.0% | +74.6% |
| RSI (14)Momentum oscillator 0–100 | 59.7 | 71.2 |
| Avg Volume (50D)Average daily shares traded | 239K | 273K |
Analyst Outlook
DORM leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates THRM as "Buy" and DORM as "Buy". Consensus price targets imply 19.0% upside for THRM (target: $37) vs 12.4% for DORM (target: $140).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $36.67 | $140.00 |
| # AnalystsCovering analysts | 15 | 16 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | +1.1% |
DORM leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). THRM leads in 1 (Valuation Metrics). 1 tied.
THRM vs DORM: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is THRM or DORM a better buy right now?
For growth investors, Dorman Products, Inc.
(DORM) is the stronger pick with 6. 0% revenue growth year-over-year, versus 2. 6% for Gentherm Incorporated (THRM). Dorman Products, Inc. (DORM) offers the better valuation at 18. 8x trailing P/E (15. 0x forward), making it the more compelling value choice. Analysts rate Gentherm Incorporated (THRM) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — THRM or DORM?
On trailing P/E, Dorman Products, Inc.
(DORM) is the cheapest at 18. 8x versus Gentherm Incorporated at 51. 4x. On forward P/E, Gentherm Incorporated is actually cheaper at 11. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — THRM or DORM?
Over the past 5 years, Dorman Products, Inc.
(DORM) delivered a total return of +19. 2%, compared to -58. 0% for Gentherm Incorporated (THRM). Over 10 years, the gap is even starker: DORM returned +129. 7% versus THRM's -14. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — THRM or DORM?
By beta (market sensitivity over 5 years), Dorman Products, Inc.
(DORM) is the lower-risk stock at 0. 85β versus Gentherm Incorporated's 1. 43β — meaning THRM is approximately 68% more volatile than DORM relative to the S&P 500. On balance sheet safety, Gentherm Incorporated (THRM) carries a lower debt/equity ratio of 41% versus 43% for Dorman Products, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — THRM or DORM?
By revenue growth (latest reported year), Dorman Products, Inc.
(DORM) is pulling ahead at 6. 0% versus 2. 6% for Gentherm Incorporated (THRM). On earnings-per-share growth, the picture is similar: Dorman Products, Inc. grew EPS 8. 1% year-over-year, compared to -70. 9% for Gentherm Incorporated. Over a 3-year CAGR, THRM leads at 7. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — THRM or DORM?
Dorman Products, Inc.
(DORM) is the more profitable company, earning 9. 6% net margin versus 1. 2% for Gentherm Incorporated — meaning it keeps 9. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DORM leads at 16. 8% versus 5. 2% for THRM. At the gross margin level — before operating expenses — DORM leads at 41. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is THRM or DORM more undervalued right now?
On forward earnings alone, Gentherm Incorporated (THRM) trades at 11.
6x forward P/E versus 15. 0x for Dorman Products, Inc. — 3. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for THRM: 19. 0% to $36. 67.
08Which pays a better dividend — THRM or DORM?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is THRM or DORM better for a retirement portfolio?
For long-horizon retirement investors, Dorman Products, Inc.
(DORM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 85), +129. 7% 10Y return). Both have compounded well over 10 years (DORM: +129. 7%, THRM: -14. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between THRM and DORM?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.